Both in Pharmaceuticals
Emergent Biosolutions vs Enanta Pharmaceuticals
Over the past year EBS returned −26.8% and ENTA returned +11.4%; their daily moves had a correlation of 0.24.
EBS −26.8% ENTA +11.4%Growth of $1, one year, split-adjusted
| Metric | EBS | ENTA |
|---|---|---|
| Price | $6.93 | $11.66 |
| Market cap | $355.3M | $339.6M |
| Today | +3.90% | −4.27% |
| 1 month | +0.1% | −7.8% |
| 6 months | −13.3% | −15.9% |
| Year to date | −43.9% | −26.1% |
| 1 year | −28.5% | +11.0% |
| Revenue growth (YoY) | +66.3% | −21.6% |
| Gross margin | 58.6% | 100.0% |
| Net margin | −76.9% | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 5.2× |
| Net cash | -$442.1M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 97.4% | 44.4% |
| Short % of float | 19.3% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).